UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’

Bastian, Mike; Freemantle, Nick; Rossi, Ana B; Shumel, Brad; Le Bagousse, Gaelle Bego; Wang, Zhixiao; Xu, Yingxin; (2024) Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’. Dermatology and Therapy , 14 (3) pp. 819-821. 10.1007/s13555-024-01106-2. Green open access

[thumbnail of s13555-024-01106-2.pdf]
Preview
Text
s13555-024-01106-2.pdf - Published Version

Download (180kB) | Preview
Type: Article
Title: Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’
Location: Switzerland
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s13555-024-01106-2
Publisher version: http://dx.doi.org/10.1007/s13555-024-01106-2
Language: English
Additional information: This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Keywords: Atopic dermatitis; Dupilumab; Eczema; Lebrikizumab; Matching-adjusted indirect comparison
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > Comprehensive CTU at UCL
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10191860
Downloads since deposit
574Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item